Efficacy and Safety of Topical siRNA-Based Formulation Targeting DKK-1 in Androgenetic Alopecia: A Randomized, Double-Blind, Vehicle-Controlled Trial
August 2026
in “
Journal of the American Academy of Dermatology
”
Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer